First serological evidence of MERS-CoV in dromedary camels from Algeria

Comp Immunol Microbiol Infect Dis. 2023 Dec:103:102078. doi: 10.1016/j.cimid.2023.102078. Epub 2023 Oct 19.

Abstract

Middle East Respiratory Syndrome (MERS) is a zoonotic disease. Dromedary camel is responsible of its transmission to humans. Accordingly, several human cases have been reported worldwide with a high mortality rate. In Algeria, no data reported on MERS prevalence in camels. This is a first seroprevalence study MERS-CoV in Algerian dromedaries. A total of 87 camel blood samples from EL -MENIAA and Ghardaia, were analyzed by anti-MERS-CoV IgG ELISA camel. The seroprevalence was 64 % and it significantly increases with age. Larger serological and molecular screening is needed to precisely determine the rate of MERS active circulation among Algerian dromedary population.

Keywords: Algeria; Dromedary; ELISA; MERS-CoV; Seroprevalence.

MeSH terms

  • Algeria / epidemiology
  • Animals
  • Camelus
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / veterinary
  • Humans
  • Middle East Respiratory Syndrome Coronavirus* / genetics
  • Seroepidemiologic Studies